Hairstetics Overview
Hairstetics developed state-of-the-art hair implants. Its product – Hairstetics Hair Implant Device, a multiple-hair implantation device, with an anchoring system was developed to provide an unmatched non-surgical, no downtime, lunch time procedure treatment for Alopecia and hair loss. Hairstetics is focusing in bringing a unique solution to women androgenetic alopecia and later to all Alopecia effected population. To the doctors Hairstetics is offering user-friendly devices easily operated by a physician in a fraction of the time compared to existing solution of natural hair transplantation.
Cumulative Funding Raised Over Time ($)
$4.0MJul 2014
$4.1MJun 2018
$5.8MNov 2012
$6.3MNov 2023
$7.4MSep 2022
Latest News
growth-positive
/PRNewswire/ -- Hairstetics is expanding its award-winning, patented medical procedure that enables the minimally invasive implantation of synthetic hair...
Hairstetics is expanding its innovative medical procedure for female hair loss, which involves the minimally invasive implantation of synthetic hair fibers. The company has secured a €2 million investment from Cutia Therapeutics, granting them exclusive rights to market Hairstetics solution in China. This strategic partnership aims to tap into the growing Chinese hair loss therapeutics market. Hairstetics has raised $17 million to date from various investors and is led by CEO Oren Neeman. The company has received international recognition for its innovation in medical aesthetics and aims to capture a significant share of the global hair restoration market.
InvestmentPartnersCustomers
growth-positive
חברת Hairstetics המטפלת בהתקרחות נשית הודיעה על השקעה אסטרטגית; בית החולים שיבא מקים מרכז מחקר עם בר-אילן ומרכז חדשנות עם המרכז הרפואי זיו; טרהסייט תפתח מודל בינה מלאכותית בתחום הביולוגיה; ונוירוקייר תתאים תרופות לטיפול בדיכאון באמצעות "מוח קטן בצלחת" ● השבוע בביומד
Hairstetics, a company specializing in synthetic hair injection technology for women experiencing hair loss, has secured a strategic investment of 2 million euros from the Chinese public company Cutia Therapeutics. This investment will allow Hairstetics to expand its market presence, particularly in China and Hong Kong, where Cutia has acquired marketing rights. Hairstetics technology offers a less invasive alternative to traditional hair transplantation methods, providing a full coverage solution in under an hour. The company has already raised approximately 17 million dollars from various investors and holds CE approval, with its technology being marketed in France and Israel.
InvestmentPartners
growth-positive
One-hour transplants for women with genetic hair loss - ISRAEL21c
Hairstetics, a femtech company, has developed a minimally invasive procedure for filling in bald areas caused by androgenetic alopecia. The procedure uses a device pre-loaded with cartridges holding synthetic strands mechanically connected to a miniature anchor for fixation to the scalp. The procedure is currently available in Israel, France, Belgium, and Switzerland. Approximately 500 women have undergone the procedure. The company was founded in 2010 by Dvir Keren and Boaz Shenhav. Its major shareholder is Peregrine Ventures, and it has also received support from private Swiss investors.
CustomersExpand
growth-positive
Instant Implants Give Balding Women Their Hair Back
Israeli medical technology company Hairstetics has developed a near-instant hair implant for women suffering from androgenetic alopecia, a genetic disorder characterized by permanent hair loss. The implants, which are made from the same material as surgical sutures, can restore a womans hair in less than an hour without surgical intervention. The procedure is currently available in Israel, Brazil, France, Switzerland, and Belgium, with plans for future expansion into the American market pending FDA approval. The average cost of the procedure is between 5,000-6,000 euros.
CustomersExpand
growth-positive
פרס IMCAS בחדשנות ברפואה אסתטית הוענק לחברת הסטארט-אפ הישראלית היירסטטיקס - וואלה! כסף
HairStetics, an Israeli startup, won the first prize for innovation at the IMCAS annual international conference for aesthetic medicine. The company developed a groundbreaking technology for synthetic hair injection, which was recognized for its potential to revolutionize hair restoration. The technology is approved by the Israeli Ministry of Health and has CE certification, allowing it to be marketed across Europe. The company plans to use this recognition to expand globally. The event was held online due to COVID-19 restrictions, and the award was presented by a panel of top doctors and industry leaders.
CustomersPartners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $7.42M |
| Last funding | $500K |
| Stage | B |
| Rounds | 5 |
| Investors | 3 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | hairstetics.com |
Locations
Yoni Netanyahu St 6, Or Yehuda, Israel
Yoni Netanyahu St, Or Yehuda, Israel
Photos & Videos
2 item(s)
Hairstetics Business
Business models
B2B, B2C
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersConsumersRecreational & LifestyleCore Technology
—Tags (6)
clinicsnon-surgicalmedical-devicesminimally-invasivewomenwell-beingGeographic Markets
EuropeChinaBrazilHairstetics Financials
$7.42M
Total funding
Undisclosed
Capital raised
$500K
Last funding
B
Funding stage
5
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
$4.0MJul 2014
$4.1MJun 2018
$5.8MNov 2012
$6.3MNov 2023
$7.4MSep 2022
Private Equity Funding
Undisclosed Round
Nov 2023
$500K
Peregrine Ventures
Undisclosed Round
Sep 2022
$1.1M
Peregrine Ventures
Undisclosed Round
Jun 2018
$123K
Peregrine Ventures (Lead)
B Round
Jul 2014
$4M
Undisclosed Investor(s)
A Round
Nov 2012
$1.7M
Crossroad Venture Capital Fund
Hairstetics Lifecycle
Cumulative Funding Raised Over Time
$4.0MJul 2014
$4.1MJun 2018
$5.8MNov 2012
$6.3MNov 2023
$7.4MSep 2022
All Events
Undisclosed Round
Nov 2023
$500K
Peregrine Ventures
Undisclosed Round
Sep 2022
$1.1M
Peregrine Ventures
Undisclosed Round
Jun 2018
$123K
Peregrine Ventures (Lead)
B Round
Jul 2014
$4M
Undisclosed Investor(s)
A Round
Nov 2012
$1.7M
Crossroad Venture Capital Fund
Hairstetics News
6 articles
growth-positive
/PRNewswire/ -- Hairstetics is expanding its award-winning, patented medical procedure that enables the minimally invasive implantation of synthetic hair...
Hairstetics is expanding its innovative medical procedure for female hair loss, which involves the minimally invasive implantation of synthetic hair fibers. The company has secured a €2 million investment from Cutia Therapeutics, granting them exclusive rights to market Hairstetics solution in China. This strategic partnership aims to tap into the growing Chinese hair loss therapeutics market. Hairstetics has raised $17 million to date from various investors and is led by CEO Oren Neeman. The company has received international recognition for its innovation in medical aesthetics and aims to capture a significant share of the global hair restoration market.
InvestmentPartnersCustomers
growth-positive
חברת Hairstetics המטפלת בהתקרחות נשית הודיעה על השקעה אסטרטגית; בית החולים שיבא מקים מרכז מחקר עם בר-אילן ומרכז חדשנות עם המרכז הרפואי זיו; טרהסייט תפתח מודל בינה מלאכותית בתחום הביולוגיה; ונוירוקייר תתאים תרופות לטיפול בדיכאון באמצעות "מוח קטן בצלחת" ● השבוע בביומד
Hairstetics, a company specializing in synthetic hair injection technology for women experiencing hair loss, has secured a strategic investment of 2 million euros from the Chinese public company Cutia Therapeutics. This investment will allow Hairstetics to expand its market presence, particularly in China and Hong Kong, where Cutia has acquired marketing rights. Hairstetics technology offers a less invasive alternative to traditional hair transplantation methods, providing a full coverage solution in under an hour. The company has already raised approximately 17 million dollars from various investors and holds CE approval, with its technology being marketed in France and Israel.
InvestmentPartners
growth-positive
One-hour transplants for women with genetic hair loss - ISRAEL21c
Hairstetics, a femtech company, has developed a minimally invasive procedure for filling in bald areas caused by androgenetic alopecia. The procedure uses a device pre-loaded with cartridges holding synthetic strands mechanically connected to a miniature anchor for fixation to the scalp. The procedure is currently available in Israel, France, Belgium, and Switzerland. Approximately 500 women have undergone the procedure. The company was founded in 2010 by Dvir Keren and Boaz Shenhav. Its major shareholder is Peregrine Ventures, and it has also received support from private Swiss investors.
CustomersExpand
growth-positive
Instant Implants Give Balding Women Their Hair Back
Israeli medical technology company Hairstetics has developed a near-instant hair implant for women suffering from androgenetic alopecia, a genetic disorder characterized by permanent hair loss. The implants, which are made from the same material as surgical sutures, can restore a womans hair in less than an hour without surgical intervention. The procedure is currently available in Israel, Brazil, France, Switzerland, and Belgium, with plans for future expansion into the American market pending FDA approval. The average cost of the procedure is between 5,000-6,000 euros.
CustomersExpand
growth-positive
פרס IMCAS בחדשנות ברפואה אסתטית הוענק לחברת הסטארט-אפ הישראלית היירסטטיקס - וואלה! כסף
HairStetics, an Israeli startup, won the first prize for innovation at the IMCAS annual international conference for aesthetic medicine. The company developed a groundbreaking technology for synthetic hair injection, which was recognized for its potential to revolutionize hair restoration. The technology is approved by the Israeli Ministry of Health and has CE certification, allowing it to be marketed across Europe. The company plans to use this recognition to expand globally. The event was held online due to COVID-19 restrictions, and the award was presented by a panel of top doctors and industry leaders.
CustomersPartners
growth-positive
Crossroad Fund to invest NIS 6m in hair restoration co Hairstetics
Maayan Ventures portfolio company, Hairstetics, has received a NIS 6 million investment from the Crossroad Fund. The investment will be made in phases and is dependent on milestone payments. Hairstetics is developing innovative hair restoration devices. The investment, along with a previous investment from Pontifax Fund, ensures the continued financing of the company and speeds up its market entry. The hair implant market is transitioning from complex surgical procedures to procedures resembling Botox injections, and Hairstetics technology aligns with this trend.
Investment
Hairstetics Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 9 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Hairstetics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 514436278 |
| Crunchbase | hairstetics |
| Phone | +97235219999 |
| Creator | Raz Zohar |
| Creator email | raz@platterz.ca |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-03-12T00:00:00.000Z |
| Created | 2014-09-07T00:00:00.000Z |
| Claimed | Yes |